Skip to content

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03032159
Acronym
T2B
Enrollment
221
Registered
2017-01-26
Start date
2015-08-31
Completion date
2020-03-31
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention (Text2Breathe) designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).

Detailed description

Potentially eligible participants are approached and screened in person during an admission of their child to the emergency department for asthma care. Those participants randomized to the intervention will receive additional education on effective communication with their child's primary care provider (PCP). These participants will also receive educational text messages for three months after their initial visit. Text messages will include education on effectively communicating with their child's provider and general asthma information. Both the control group and intervention group will receive text message reminders to schedule regular follow up visits with their PCP and get an annual flu shot. Both groups will be contacted for follow up phone interviews at 3, 6, 12, 18 and 24 months.

Interventions

BEHAVIORALText2Breathe Study Group

Sponsors

MultiCare Mary Bridge Children's Hospital & Health Center
CollaboratorOTHER
Seattle Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unlimited text messaging Is the parent of child who is: * Receiving asthma related care in the emergency department * 2-12 years old inclusive * Medicaid insured (no Private insurance) * Physician diagnosed asthma for at least 12 months

Exclusion criteria

Is the parent of child who: * Has seen a pulmonary or allergy sub-specialist more than once in the last 6 months * Has seen a sub-specialist (not pulmonary or allergy) more than once in the last 12 months * Has been hospitalized for more than 30 days * Is currently enrolled in another asthma program or study

Design outcomes

Primary

MeasureTime frameDescription
Emergency Department Visits for Asthma Care12 monthsNumber of emergency department visits for asthma care

Secondary

MeasureTime frameDescription
Asthma Morbidity12 monthsAsthma morbidity measured as the number of days (or nights) of impairment.

Other

MeasureTime frameDescription
Parental Expectations for Child's Asthma Treatment Average Score12 monthsIn accordance with other research of pediatric asthma interventions, to assess parents' beliefs about possible asthma quality of life for their child we will administer an 8-item measure of parental expectations for asthma treatment. Parents respond to statements about their expectations (e.g., I believe that my child can be symptom free most of the time.) using a 5-point Likert scale (1=strongly disagree to 5=strongly agree). Total scores are calculated by averaging across responses, and higher scores reflect more optimistic asthma outcome expectations (Cronbach's alpha = 0.70).
Number of Scheduled Asthma Care Visits12 monthsNumber of visits with PCP for preventative asthma care in past 12 months
Parental Asthma Management Self-efficacy Scale Summary Score12 monthsThe Parent Asthma Management Self-Efficacy Scale (PAMSES) is a valid and reliable instrument designed to measure parent self-efficacy in preventing and managing children's asthma attacks. The PAMSES consists of 13 items rated on a 5-point Likert scale (1=not at all sure to 5=completely sure) with a total possible score range of 13 to 65; higher scores indicate greater self-efficacy. Cronbach's alpha in a sample of primarily White mothers was 0.87.
Parental Self-efficacy for Communicating With Healthcare Providers Self-competence Scale Summary Score12 monthsThe Medical Competence Communication Scale (MCCS) measures patient's perceptions of their own communication during their most recent medical visits. The patient version of the measure is used to assess information giving, seeking and verifying, as well as socio-emotional communication. The MCCS, patient version, consists of 23 items rated on a 5-point Likert scale (1= unimportant to 5= important) with a higher score indicating greater perception of communication competence (range 16-80). Cronbach's alpha ranges from 0.76-0.92 on the various subscales. Only the 16 self-competence items will be administered in this study. Wording of questions will be modified to state my child's medical problem rather than my medical problem.
Asthma Self-Management Questionnaire Standardized Score12 monthsThe Asthma Self-Management Questionnaire, recommended by experts convened for the Asthma Outcomes workshop, includes 16 multiple-choice questions regarding knowledge of preventive strategies and controller medication use. Standardized scores (0-100) are generated, with higher scores indicating more knowledge of self-management. Cronbach's alpha was 0.71. Wording of questions has been revised (e.g., you = your child) to be appropriate for parents of children with asthma.

Countries

United States

Participant flow

Recruitment details

Participants (parents) were recruited from two children's hospitals in Seattle and Tacoma, Washington from 2015-2019.

Pre-assignment details

Of the 661 potential parent participants screened for eligibility, 221 were eligible and randomized. Participants are unique parent/child dyads. The parents were enrolled, and each parent had a child that they provided data on. Those that were screened but excluded either did not meet inclusion criteria or declined to participate.

Participants by arm

ArmCount
Control Group
Parents randomized to the control group child will receive their usual asthma care from their provider. Additionally, parents in the control group will receive reminder texts to schedule with their child's PCP and to get an annual flu shot. Parents will be surveyed over the phone for 20-30 minutes 3, 6, 12, 18, and 24 months after enrollment.
110
Text2Breathe Study Group
Parents in the study group spend about 10-20 minutes learning about ways to have better communication with their child's primary care provider about his/her asthma. Additionally, parents in this group enrolled in the Text2Breathe messaging program which sends asthma related educational text messages 2 times a week for 3 months. Parents randomized to the study group will also receive reminder texts to schedule with their child's PCP and to get an annual flu shot. Parents will be surveyed over the phone for 20-30 minutes 3, 6, 12, 18, and 24 months after enrollment. Text2Breathe Study Group
111
Total221

Baseline characteristics

CharacteristicControl GroupText2Breathe Study GroupTotal
Age, Continuous5.0 years
STANDARD_DEVIATION 2.3
6.4 years
STANDARD_DEVIATION 2.9
5.8 years
STANDARD_DEVIATION 2.7
Race/Ethnicity, Customized
Parent race and ethnicity
Latino
35 Participants36 Participants71 Participants
Race/Ethnicity, Customized
Parent race and ethnicity
Missing
2 Participants6 Participants8 Participants
Race/Ethnicity, Customized
Parent race and ethnicity
Multiracial
2 Participants12 Participants14 Participants
Race/Ethnicity, Customized
Parent race and ethnicity
Non-Latino Black
24 Participants18 Participants42 Participants
Race/Ethnicity, Customized
Parent race and ethnicity
Non-Latino White
32 Participants28 Participants60 Participants
Race/Ethnicity, Customized
Parent race and ethnicity
Other
15 Participants11 Participants26 Participants
Region of Enrollment
United States
110 participants111 participants221 participants
Sex: Female, Male
Female
97 Participants101 Participants198 Participants
Sex: Female, Male
Male
13 Participants10 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1100 / 111
other
Total, other adverse events
0 / 1100 / 111
serious
Total, serious adverse events
0 / 1100 / 111

Outcome results

Primary

Emergency Department Visits for Asthma Care

Number of emergency department visits for asthma care

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Control GroupEmergency Department Visits for Asthma Care1.65 ED visitsStandard Deviation 1.7
Text2Breathe Study GroupEmergency Department Visits for Asthma Care1.95 ED visitsStandard Deviation 2.7
Secondary

Asthma Morbidity

Asthma morbidity measured as the number of days (or nights) of impairment.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Control GroupAsthma Morbidity3.36 max symptom daysStandard Deviation 4.4
Text2Breathe Study GroupAsthma Morbidity4.45 max symptom daysStandard Deviation 5
Other Pre-specified

Asthma Self-Management Questionnaire Standardized Score

The Asthma Self-Management Questionnaire, recommended by experts convened for the Asthma Outcomes workshop, includes 16 multiple-choice questions regarding knowledge of preventive strategies and controller medication use. Standardized scores (0-100) are generated, with higher scores indicating more knowledge of self-management. Cronbach's alpha was 0.71. Wording of questions has been revised (e.g., you = your child) to be appropriate for parents of children with asthma.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Control GroupAsthma Self-Management Questionnaire Standardized Score59.68 score on a scaleStandard Deviation 17.2
Text2Breathe Study GroupAsthma Self-Management Questionnaire Standardized Score58.67 score on a scaleStandard Deviation 19.6
Other Pre-specified

Number of Scheduled Asthma Care Visits

Number of visits with PCP for preventative asthma care in past 12 months

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Control GroupNumber of Scheduled Asthma Care Visits2.07 number of visitsStandard Deviation 1.7
Text2Breathe Study GroupNumber of Scheduled Asthma Care Visits2.80 number of visitsStandard Deviation 3
Other Pre-specified

Parental Asthma Management Self-efficacy Scale Summary Score

The Parent Asthma Management Self-Efficacy Scale (PAMSES) is a valid and reliable instrument designed to measure parent self-efficacy in preventing and managing children's asthma attacks. The PAMSES consists of 13 items rated on a 5-point Likert scale (1=not at all sure to 5=completely sure) with a total possible score range of 13 to 65; higher scores indicate greater self-efficacy. Cronbach's alpha in a sample of primarily White mothers was 0.87.

Time frame: 12 months

Other Pre-specified

Parental Expectations for Child's Asthma Treatment Average Score

In accordance with other research of pediatric asthma interventions, to assess parents' beliefs about possible asthma quality of life for their child we will administer an 8-item measure of parental expectations for asthma treatment. Parents respond to statements about their expectations (e.g., I believe that my child can be symptom free most of the time.) using a 5-point Likert scale (1=strongly disagree to 5=strongly agree). Total scores are calculated by averaging across responses, and higher scores reflect more optimistic asthma outcome expectations (Cronbach's alpha = 0.70).

Time frame: 12 months

Other Pre-specified

Parental Self-efficacy for Communicating With Healthcare Providers Self-competence Scale Summary Score

The Medical Competence Communication Scale (MCCS) measures patient's perceptions of their own communication during their most recent medical visits. The patient version of the measure is used to assess information giving, seeking and verifying, as well as socio-emotional communication. The MCCS, patient version, consists of 23 items rated on a 5-point Likert scale (1= unimportant to 5= important) with a higher score indicating greater perception of communication competence (range 16-80). Cronbach's alpha ranges from 0.76-0.92 on the various subscales. Only the 16 self-competence items will be administered in this study. Wording of questions will be modified to state my child's medical problem rather than my medical problem.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Control GroupParental Self-efficacy for Communicating With Healthcare Providers Self-competence Scale Summary Score78.72 score on a scaleStandard Deviation 3.1
Text2Breathe Study GroupParental Self-efficacy for Communicating With Healthcare Providers Self-competence Scale Summary Score78.63 score on a scaleStandard Deviation 3.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026